Osi Pharmaceuticals trims 2010 revenue outlook
OSI Pharmaceuticals Inc. on Tuesday trimmed its 2010 revenue outlook citing a potential regulatory roadblock to the cancer drug Tarceva.
Valley Forged-based pharmaceutical wholesaler AmerisourceBergen said Thursday that its quarterly revenue rose 5.7 percent from the same period in 2011.